Globus Medical launches ExcelsiusGPS in EU

Globus Medical (NYSE:GMED) said yesterday that it launched its ExcelsiusGPS robotic guidance and navigation system in the global market, having completed installations of the system in several European countries. The ExcelsiusGPS system won CE Mark clearance in the EU in early 2017 with indications for use in both minimally invasive and open procedures for orthopedics and neurosurgery, including procedures for the spine, long bones and cranium. The system is designed to integrate with Globus Medical implants and instruments, with compatibility with pre- and intra-operative CT and fluoroscopic imaging, the company said. “Surgeons and hospital administrators in the United States have shown tremendous levels of interest in ExcelsiusGPS since it first launched domestically at the end of 2017. Users have realized the system’s ability to help advance patient care and provide tangible benefits for surgeons and their staff. As we begin to scale our efforts abroad, we have seen similar levels of enthusiasm within the international surgeon community and look forward to the continued adoption of ExcelsiusGPS into these markets,” CEO Dave Demski said in a prepared statement. The Audobon, Penn.-based company touted that the first European procedure using the ExcelsiusGPS was performed at Athens, Greece’s Metropolitan Hospital by Dr. Panagiotis Zoumpoulis in October, and that numerous other surgeries have bene performed at Italy’s Fornaca Clinic and GermanyR...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Robotics Globus Medical Source Type: news